Subscribe To
Why advisors should take a closer look at china a-shares
As China looks past Covid-19 lockdowns, regulatory crackdowns, and other market hurdles, the government is now outlining a new ...
September 9, 2022, 7:39 pm
Trump media spac extends merger deadline
The special-purpose acquisition company trying to take Trump Media & Technology Group public will pay nearly $3 million to get three more months to co...
September 9, 2022, 1:38 pm
Erasca to present at the morgan stanley global healthcare conference
SAN DIEGO, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discoveri...
September 9, 2022, 8:31 am
Grail to present final multi-cancer early detection data from the interventional pathfinder study at esmo congress 2022
MENLO PARK, Calif.--(BUSINESS WIRE)--GRAIL announced final results from the interventional PATHFINDER study will be presented at the European Society ...
September 8, 2022, 6:05 pm
Bowlero: market leader with clear path to margin expansion
Bowl operates in a TAM that is growing, and its strong unit economics drive a larger revenue share, generating enormous cash flow for reinvestment. Th...
September 8, 2022, 9:38 am
Draftkings ceo jason robins on upcoming nfl betting season, path to profitability
DraftKings CEO Jason Robins joins CNBC's 'Squawk Box' ahead of the NFL season to discuss the company's growth forecast and its ...
September 8, 2022, 9:28 am
Uipath (path) – cathie wood adds $47m in this automation firm as shares dive 36% in a month
Cathie Wood-led Ark Investment Management bought over 3.4 million shares of software company Uipath Inc...
September 7, 2022, 10:03 pm
Uipath stock plunges on outlook, coupa stock pops on earnings
Yahoo Finance Live anchors Julie Hyman and Jared Blikre discuss quarterly earnings for Uipath and Coupa...
September 7, 2022, 12:11 pm
Amc stock moves lower as cineworld files for bankruptcy
Yahoo Finance anchors Julie Hyman and Jared Blikre discuss news that UK movie theater chain Cineworld has filed for Chapter 11 bankruptcy in the U.S. ...
September 7, 2022, 12:07 pm
Uipath stock opened 20% down on wednesday: find out why
Uipath Inc (NYSE: PATH) reported market-beating results for its fiscal second quarter on Wednesday. Sha...
September 7, 2022, 11:01 am
Desert mountain energy: an explosive path to success
The Inflation Reduction Act contains clauses which impact hydrogen in a very positive fashion. In time, DME may produce hydrogen in tandem with its pa...
September 7, 2022, 9:27 am
Uipath stock downgraded as repositioning 'will take some time to play out'
Mizuho analyst Siti Panigrahi downgraded shares of Uipath Inc. PATH, -3.17% Wednesday in the wake of th...
September 7, 2022, 7:35 am
Apple vs microsoft: which stock is the better long-term investment?
These former tech rivals are on divergent paths to success, but one is the better buy....
September 7, 2022, 7:03 am
Uipath stock sinks on cut to fiscal-year revenue forecast
The robotic-process automation software company reduces its outlook for fiscal-year revenue citing 'foreign exchange and macroeconomic volatility.'...
September 7, 2022, 4:14 am
Uipath inc. (path) q2 2023 earnings call transcript
Uipath Inc. (NYSE:path ) Q2 2023 Results Conference Call...
September 6, 2022, 8:43 pm
Uipath (path) reports q2 loss, tops revenue estimates
Uipath (PATH) delivered earnings and revenue surprises of 81.82% and 5.37%, respectively, for the quart...
September 6, 2022, 6:48 pm
Should you short target (tgt) stock now?
Source: jejim / Shutterstock.com Independent investment research publication Hedgeye recently targeted Target (NYSE: TGT ) stock as a potential short ...
September 6, 2022, 5:08 pm
Uipath stock drops 15% after outlook cut
Uipath Inc. shares dropped in the extended session Tuesday after the “software robot” provider redu...
September 6, 2022, 4:31 pm
Fsd pharma wins fda and health canada approval for ind for phase 2 trial of fsd201 for treating inflammatory disorder
FSD Pharma Inc (CSE:HUGE, NASDAQ:HUGE) revealed that it has received a study may proceed letter for its Investigational New Drug (IND) application fr...
September 6, 2022, 10:48 am
Gds holdings: best-in-class operator trading at a discount
GDS' results remain pressured amid operating challenges in China. Unsurprisingly, guidance was also lowered for 2022, though the long-term expansion <...
September 6, 2022, 2:22 am